Interacting drugs- summary

+Meningococcal Vaccine 

 Measles (Rubeola )                                                                                                           reduced seroconversion rate to meningococci occur with vaccine concurrent immunization. 

Prophylaxis against cerebro-spinal menigingtis due to meningocococci of A& C groups

Systemic- Headache 1.2 to 4.1%      Malaise < 2.6%     Fever 0.4% to 3.1%

Chills < 1.7%

Local- Tenderness 24.2 to 29.1% Pain 17,5 to 25%.

Erythema 0.8% to 31.7%       Induration 4.8 to 8.3%

Acute illness, pregnancy

Prophylaxis against cerebro-spinal menigingtis due to meningocococci of A& C groups Routine vaccination- at risk of epidemic ot highly endemic areas

Dosage-

Inject SC- avoid injecting intraderdermally or IV Immunization dose is one SC injection of 0.5ml